Iris Liou, MD
Disclosures:
Anne M

Curriculum Vitae

Iris W. Liou, MD

University of Washington Medical Center

Box 356175; Rm NN-418

1959 NE Pacific Street

Seattle, WA 98195-6175

(206) 598-4908

 

PERSONAL DATA

              Birthdate:              May 14, 1975              Citizenship:  United States of America

              Birthplace:              East Orange, NJ

EDUCATION

              1996              B.S.              with Distinction, Cell and Molecular Biology; Summa Cum Laude; University of Washington, Seattle, WA

              2000              M.D.              University of Washington School of Medicine, Seattle, WA

POSTGRADUATE TRAINING

              2000-2003              Residency, Internal Medicine, Traditional Track, University of Washington, Seattle, WA

              2003-2004              Chief Residency, Internal Medicine, Seattle VA, University of Washington, Seattle, WA

2004-2007              Fellowship, Gastroenterology, University of Washington, Seattle, WA

Chief Fellow 2006-2007

              2007-2008              Fellowship, Transplant Hepatology, University of Washington, Seattle, WA

              2011-2012              Scholar, Teaching Scholars Program, University of Washington, Seattle, WA

              2015-2016              Student, UW Medicine and Seattle Children’s Hospital Certificate Program in Patient Safety and Quality,

University of Washington, Seattle, WA

 

FACULTY POSITIONS HELD

              2008-2014              Assistant Professor, University of Washington, Seattle, WA

              2014-2016              Clinical Assistant Professor, University of Washington, Seattle, WA

              2016-                            Clinical Associate Professor, University of Washington, Seattle, WA

 

HOSPITAL POSITIONS HELD

              2008-                            Active Medical Staff, University of Washington Medical Center, Seattle, WA

              2008-                            Associate Medical Staff, Harborview Medical Center, Seattle, WA

              2008-                            Associate Medical Staff, Seattle Cancer Care Alliance, Seattle, WA

              2008-                            Director, Hepatology Clinic, University of Washington Medical Center, Seattle, WA

 

AWARDS and HONORS

              1993              National Merit Scholarship

              1995              Hughes Summer Research Program Grant

              1996              Mortar Board Senior Honor Society

              1996              Golden Key National Honor Society

              1996              Phi Beta Kappa

              1997              Medical Student Research Training Program Grant

              2002              Pfizer Excellence in Internal Medicine Resident Award

             

BOARD CERTIFICATION:

                                                        USMLE ID# 5-036-118-7

              2002                            Diplomate, National Board of Medical Examiners

              2003-2013              Diplomate, American Board of Internal Medicine (#218588)

              2007                            Diplomate, American Board of Internal Medicine, Gastroenterology (#218588)– expires 12-31-2017

              2008                            Diplomate, American Board of Internal Medicine, Transplant Hepatology (#218588)—expires 12-31-2018

 

LICENSURE:

              2003              Washington License, No. MD00042419

              1994              Drug Enforcement Administration, No. BL6996295

PROFESSIONAL SOCIETY MEMBERSHIPS

              American College of Physicians—American Society of Internal Medicine

              American Association for the Study of Liver Diseases

              American College of Gastroenterology

              American Gastroenterological Association

              American Society for Gastrointestinal Endoscopy (2004-2007)

              American Society of Transplantation (2007-2008)

TEACHING RESPONSIBILITIES

              Multiple hospital, housestaff, and CME presentations

              Teaching Fellows, Residents, and Students in Hepatology and Liver Transplantation

 

EDITORIAL RESPONSIBILITIES

              None

 

 

SPECIAL NATIONAL RESPONSIBILITIES

              None

 

SPECIAL LOCAL RESPONSIBLITIES

              None

 

AD HOC REVIEWER

              Case Reports in Medicine

              Gastroenterology Research and Practice

              BMC Gastroenterology

              Liver Transplantation

 

1

 


Iris W. Liou, M.D.

Augmented Curriculum Vitae

 

RESEARCH AND PROJECTS IN PROGRESS

1.              Acute Liver Failure Study Group (NIH multi-center clinical study)

              a. Ancillary Studies Committee (2010-present; Chair 2012-present)

              b. ICU Checklist Committee (Co-Chair 2010-present)

              c. CRF Working Group (2010-present)

2.              Hepatocellular Carcinoma Consortium

 

RESEARCH FUNDING

 

2 UO1 DK058369-16 (William Lee)              9/1/15 – 8/31/20              5%

NIH/NIDDK             

A Multi-Center Trial for Acute Liver Failure (ALF)

Goal - in patients with severe ALI/ALF to (1) gather data concerning ALF etiology, natural history, and pathogenesis, (2) create a tissue and serum bank, and (3) study new therapies for ALF.

 

PATIENT CARE ACTIVITIES

Attending Physician; Inpatient Hepatology/Transplant Service

Attending Physician; Hepatology Clinic

Attending Physician; Liver Transplant Clinic

Attending Physician; Liver Tumor Clinic

 

COMMUNITY SERVICE

              Clinical consultant for University of Washington’s free medical information service for community practitioners (“MedCon”)

              Clinical consultant for Project ECHO (Extension for Community Healthcare Outcomes), telemedicine for liver disease

 

COMMITTEES

              University of Washington, Medicine Housestaff Representative, 2000-2002

              University of Washington, Institutional Residency and Fellowship Advisory Committee, 2003-2004

              University of Washington, Gastroenterology Fellowship Curriculum Committee, 2008- present

              UW GI Medicine Strategic Planning Committee—Viral Hepatitis Subcommittee, 2009-2010

              University of Washington Medical Center, Liver Dialysis Committee, 2009-present

              University of Washington Medical Center, Transplant Readmission Committee, 2010-2011

              University of Washington Medical Center, Transfer Task Force Committee, 2011-2012

              University of Washington, Gastroenterology Fellowship Clinical Competency Committee, 2012-present

              University of Washington, Heart and Liver Protocol Development Committee, 2012-present

              University of Washington, Acute Liver Failure Guideline Development Committee, 2013-present

              University of Washington, ABO Incompatible Liver Transplant Guideline Development Committee, 2014-2015

 

PUBLICATIONS

Peer-Reviewed Publications

  1. Liou I, Kowdley KV.  Natural history of nonalcoholic steatohepatitis.  J Clin Gastroenterol 2006; 40(S1):  S11-16.
  2. Ioannou GN, Liou IW, Weiss NS.  Serum bilirubin and colorectal cancer risk:  a population-based cohort study.  Aliment Pharmacol Ther 2006; 23(11):  1637-1642.
  3. Stepan C, Liou I, Surawicz CM.  Management of acute infectious diarrhea.  J Clin Outcomes Manage 2006; 13(7):  382-391.
  4. Liou IW, Larson AM.  Role of transplantation in acute liver failure.  Semin Liver Dis 2008; 28(2):  201-209.
  5. Zeuzem S, Sulkowski MS, Lawitz EJ, Rustgi VK, Rodriguez-Torres M, Bacon BR, Grigorescu M, Tice AD, Lurie Y, Cianciara J, Muir AJ, Cronin PW, Pulkstenis E, Subramanian GM, McHutchinson JG; ACHIEVE-1 Study Team.  Albinterferon alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 1.  Gastroenterology 2010; 139(4): 1257-1266.
  6. Rayhill S, Schwartz J, Ham J, Carithers R, Yu L, Bhattacharya R, Liou I, Landis C, Limaye A, Rakita R, Dick A, Healey P, Halldorson J, Bakthavatsalam R, Perkins J, Reyes J.  The use of hepatitis B core antibody-positive donor livers does not appear to have a deleterious effect on graft survival in liver transplantation for hepatitis C.  Transplant Proc 2010; 42(10): 4141-4144.
  7. Diamond DL, Krasnoselsky L, Burnum KE, Monroe ME, Webb-Robertson BJ, McDermott JE, Yeh MM, Dzib JF, Susnow N, Strom S, Proll SC, Belisle SE, Purdy DE, Rasmussen AL, Walters KA, Jacobs JM, Critsenko MA, Camp DG, Bhattcharya R, Perkins JD, Carithers RL Jr, Liou IW, Larson AM, Benecke A, Waters KM, Smith RD, Katze MG. Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C-virus medicated liver disease posttransplantation.  Hepatology 2012; 56(1): 28-38.
  8. Jia N, Liou I, Halldorson J, Carithers R, Perkins J, Reyes J, Yeh M, Stohr E, Rao S, Lin EH. Phase 1 adjuvant trial of sorafenib in patients with hepatocellular carcinoma after orthotopic liver transplantation. Anticancer Res 2013;33(6);2797-800.
  9. Metushi IG, Sanders C; Acute Liver Failure Study Group, Lee WM, Uetrecht J. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced acute liver failure.  Hepatology 2014; 59(2); 1084-93.
  10. Court MH, Peter I, Hazarika S, Vasiadi M, Greenblatt DJ, Lee WM; Acute Liver Failure Study Group. Candidate gene polymorphisms in patients with acetaminophen-induced acute liver failure. Drug Metab Dispos 2014; 42(1): 28-32.
  11. Liou IW.  Management of end-stage liver disease.  Med Clin North Am 2014; 98(1): 119-52.
  12. Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM; US Acute Liver Failure Study Group. Outcomes and cmplications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study.  Crit Care Med 2014; 42(5): 1157-67.
  13. Karvellas CJ, Cavazos J, Battenhouse H, Durkalski V, Balko J, Sanders C, Lee WM; US Acute Liver Failure Study Group. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study.  Clin Gastroenterol Hepatol 2014; 12(11): 1942-9.
  14. Dubin PH, Yuan H, Devine RK, Hynan LS, Jain MK, Lee WM; Acute Liver Failure Study Group. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.  J Med Virol 2014; 86(9):1507-14.
  15. Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM. Congestive hepatic fibrosis score: a novel histological assessment of clinical severity.  Mod Pathol 2014;27(12):1552-8.
  16. Long D, Fix OK, Deng X, Seielstad M, Lauring AS; Acute Liver Failure Study Group.  Whole genome sequencing to identify host genetic risk factors for severe outcomes of hepatitis A virus infection. J Med Virol 2014; 86(10):1661-8.
  17. Fontana RJ, Ellerbe C, Durkalski VE, Rangnekar A, Reddy RK, Stravitz T, McGuire B, Davern T, Reuben A, Liou I, Fix O, Ganger DR, Chung RT, Schilsky M, Han S, Hynan LS, Sanders C, Lee WM; the US Acute Liver Failure Study Group.  Two-year outcomes in initial survivors with acute liver failure:  results from a prospective, multicentre study.  Liver Int 2015; 35(2): 370-80.
  18. Halldorson JB, Carithers RL, Bhattacharya R, Bakthavatsalam R, Liou IW, Dick AA, Reyes JD, Perkins JD. D-MELD risk capping improves post-transplant and overall mortality under Markov microsimulation.  World J Transplant 2014;4(3):206-15.
  19. Berry K, Taylor J, Liou IW, Ioannou GN. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.  Clin Gastroenterol Hepatol 2015; 13(3):585-93
  20. Ingraham CR, Padia SA, Johnson GE, Easterling TR, Liou IW, Kanal KM, Valji K. Transjugular intrahepatic portosystemic shunt placement during pregnancy: a case series of five patients. Cardiovasc Intervent Radiol 2015; 39(5):1205-10.
  21. Speiser JL, Lee WM, Karvellas CJ; US Acute Liver Failure Study Group.  Predicting outcome on admission and post-admission for acetaminophen-induced acute liver failure using classification and regression tree models. PLos One 2015;10(4):e0122929.
  22. Berry K, Lerrigo R, Liou IW, Ioannou GN.  Association between transjugular intrahepatic portosystemic shunt and survival in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015 July 17. [Epub ahead of print]
  23. James J, Liou IW. Comprehensive care of patients with chronic liver disease. Med Clin North Am 2015;99(5):913-33.
  24. Rule JA, Hynan LS, Attar N, Sanders C, Korzun WJ, Lee M; Acute Liver Failure Study Group. Procalcitonin identifies cell injury, not bacterial infection in acute liver failure. PLoS One. 2015 Sep 22; 10(9): e0138566.
  25. Kaur G, Leslie EM, Tillman H, Lee WM, Swanlund DP, Karvella CJ; US Acute Liver Failure Study Group. Detection of ophthalmic acid in serum from acetaminophen-induced acute liver failure patients is more frequent in non-survivors. PLoS One 2015;10(9):e0139299.
  26. Rosen HR, Biggins SW, Niki T, Gralla J, Hillman H, Hirashima M, Schilsky M, Lee WM; Acute Liver Failure Study Group. Association between plasma level of galectin-9 and survival of patients with drug-induced acute liver failure. Clin Gastroenterol Hepatol 2016;14(4):606-612.
  27. Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplant outcomes and transplant-related survival benefit. Gastroenterology 2016; 150(2):441-453.
  28. Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanaryana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM. Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study.  Ann Intern Med 2016; 164(11);724-32.
  29. Fix OK, Liou I, Karvellas CJ, Ganger DR, Forde KA, Subramanian RM, Boylan A, Hanje J, Stravitz RT, Lee WM; Acute Liver Failure Study Group. Development and pilot of a checklist for management of acute liver failure in the intensive care unit. PLoS One. 2016 May 13; 11(5):e0155500.
  30. Karvellas CJ, Tillman H, Leung AA, Lee WM, Schilsky ML, Hameed B, Stravitz RT, McGuire BM, Fix OK: United States Acute Liver Failure Study Group. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int 2016; 36(7):1043-50.
  31. Karvellas CJ, Cardoso FS, Gottfried M, Reddy KR, Hanje AJ, Ganger D, Lee WM; US Acute Liver Failure Study Group. HBV-associated acute liver failure after immunosuppression and risk of death. Clin Gastroenterol Hepatol 2016 Jun 13 [Epub ahead of print]
  32. Bowen SR, Chapman TR, Borgman J, Miyaoka RS, Kinahan PE, Liou IW, Sandison GA, Vesselle HJ, Nyflot MJ, Apisarnthanarax S. Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients. EJNMMI Res 2016; 6(1):57.

 

Book Chapters

  1.     Liou IW.  (2010). Miscellaneous Cystic Lesions in the Liver.  In Murray K and Larson AM (Eds), Fibrocystic Diseases of

        the Liver (pp 411-432).  New York:  Humana Press.

 

Other Publications

  1. Liou IW. Module 3: Management of Cirrhosis-Related Complications. Lessons 1-5.  Hepatitis C Online Course.  University of Washington, September 2013.  <http://www.hepatitisc.uw.edu/go/management-cirrhosis-related-complications>.
  2. Woolston SL, Liou IW. “Module 6:  Treatment of Recurrent HCV Infection following Liver Transplantation.” Hepatitis C Online Course. University of Washington, September 2015. < http://www.hepatitisc.uw.edu/go/special-populations-situations/treatment-post-transplantation/core-concept/all>.

 

  Abstracts

1.              Liou IW, Logan BK, Fligner CL.  Drug concentrations in cocaine caused and related deaths.  J Investigative Med 1998; 46(1):  99A [Abstract] (Oral presentation at 1998 Western Medical Student Research Forum, Carmel CA)

2.              Chan EY, Larson AM, Liou I, Reyes JD, Perkins JD.  Metabolic syndrome increases the risk of death in liver transplant patients with hepatocellular carcinoma.  Am J Transplant 2007; 7(2):  544A [Abstract #1545] (Presented in poster form at May 2007 American Transplant Congress meeting)

3.              Chan EY, Liou I, Larson AM, Carithers RL, Halldorson J, Levy AE, Reyes JD, Perkins JD, Bakthavatsalam R.  Preoperative risk factors to predict the development of cardiomyopathy following orthotopic liver transplantation.  Am J Transplant 2007; 7(2):  544A [Abstract #1544] (Presented in poster form at May 2007 American Transplant Congress meeting)

4.              Liou IW, Carithers RL, Jr, Perkins JD.  Outcome of transplantation for cryptogenic cirrhosis in different eras of liver transplantation.  Hepatology 2008; 48(S): 565A [Abstract #579].   (Presented in poster form at November 2008 AASLD meeting, San Francisco, CA)

5.              Halldorson JB, Carithers R, Bakthavatsalam R, Dick A, Bhattacharya R, Liou I, Reyes JD, and Perkins JD.  D-MELD risk caps for liver transplantation require adjustment for associated risk factors; implications for donor/recipient matching optimization by UNOS region and transplant center. Am J Transplant 2010; 10(S4): 136 [Abstract #323]. (Oral presentation at May 2010 American Transplant Congress meeting, San Diego, CA)

6.              Diamond DL, Rasmussen AL, Susnow NJ, Datta S, Magaret C, Webb-Robertson BM, Krasnoselsky A, Burnum KE, Yeh MY, McDermott J, Jacobs M, Gritsenko MA, Bhattacharya R, Perkins JD, Carithers RL, Liou IW, Strom S, LeCiel C, Carter VS, Purdy DE, Walters KA, Larson AM, Peng X, Proll SC, Waters KM, Smith RD, Self S, Katze MG. Hepatitis C Virus (HCV) infection and pathogenesis:  from systems biology to translational research.  Hepatology 2010; 52(S): 829A [Abstract #1056]. (Presented in poster form at November 2010 AASLD meeting, Boston, MA)

7.     Jia N, Liou I, Halldorson J, Carithers R, Perkins J, Reyes J, Yeh M, Stohr E, Rao S, Lin E. Phase I adjuvant trial of sorafenib in hepatocellular carcinoma (HCC) patients after orthotopic liver transplantation (OLT).  [Abstract 1148] (Presented in poster form at September 2011 International Society of Gastrointestinal Oncology Conference, Arlington, VA)

8.              Halldorson J, Bakthavatsalam R, Rayhill S, Leca N, Liou I, Huskey J, Pichler R.  Retransplantation with Simultaneous Liver Kidney (SLK) grafts provides greater survival compared to Liver Alone Transplantation (LA) for recipients on hemodialysis or with severe renal impairment.  Am J Transplant 2012; 12(S3): 84. [Abstract 193]. (Oral presentation at June 2012 American Transplant Congress meeting, Boston, MA)

9.              Fontana RJ, Ellerbe C, Durkalski V, Rangnekar AS, Reddy KR, McGuire BM, Davern TJ, Stravitz R, Reuben A, Liou IW, Fix OK, Lee WM.  2-year survival is significantly lower in spontaneous survivors with non-acetaminophen acute liver failure versus liver transplant recipients.  Hepatology 2012; 56(S): 191A [Abstract 2] (Transplant plenary presentation at November 2012 AASLD meeting, Boston, MA)

10.              Bentham WDL, Liou I, Perkins JD, Reyes JD, Carithers RC.  Marijuana use and liver transplant candidacy: results from a survey of medical and surgical directors of liver transplant programs in the US.  Hepatology 2012; 56(S): 343A [Abstract 309]. (Presented in poster form at November 2012 AASLD meeting, Boston, MA)

11.              Fix OK, Liou I, Karvellas D, Ganger D, Forde KA, Subramanian R, Boylan A, Stravitz RT, Lee WM.  Development and pilot of a checklist for the management of acute liver failure in the intensive care unit.  J Hepatol 2013; 58: S410 [Abstract 994]. (Presented in poster form at April 2013 EASL/The International Liver Congress meeting, Amsterdam)

12.              Fix OK, Liou I, Karvellas D, Ganger D, Forde KA, Subramanian R, Boylan A, Hanje AJ, Stravitz RT, Lee WM.  Development and pilot of a checklist for management of acute liver failure in the intensive care unit.  Gastroenterology 2013; 44(S1): S956 [Abstract 625]. (Oral presentation at May 2013 DDW meeting, Orlando, FL)

13.              Koch DG, Battenhouse H, Durkalski V, Lee WM, Liou IW, Fix OK, Ganger D, Fontana RJ, Schilsky ML, McGuire BM, Chung RT, Reddy R, Stravitz RT, Han SB.  The natural history of severe acute liver injury (ALI).  Hepatology 2013; 58(S1): 358A [Abstract 307]. (Presented in poster form at November 2013 AASLD meeting, Washington, DC)

14.               Rayhill S, Ham JM, Wu Y, Halldorson JB, Kieran N, Kendrick E, Leca N, Carithers RL, Bhattacharya R, Liou IW, Yu L, Landis CS, Lang J, Montenovo MI, Bhakthavatsalam R, Perkins JD, Dick AA, Limaye A, Rakita R, Wicks K, Kayihan A, Davis C, Reyes J.  For patients listed for simultaneous liver kidney transplantation, those who received both a liver and a kidney transplant had significantly better graft and patient survival than those who received only a liver transplant.  Hepatology 2013; 58(S1): 772A [Abstract 1153]. (Presented in poster form at November 2013 AASLD meeting, Washington, DC)

15.   Berry K, Taylor J, Liou IW, Ioannou GN. Portal vein thrombosis is not associated with increased mortality in cirrhotic patients. Hepatology 2014;60(S4): 391A [Abstract 286]. (Presented in poster form at November 2014 AASLD meeting, Boston)

16.              Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Aging of liver transplant registrants and recipients: trends and impact on transplant-related survival benefitHepatology 2015;62(S1): 808A [Abstract 1211]. (To be presented in poster form at November 2015 AASLD meeting, San Francisco)

 

 

TEACHING

              Medical School Courses

              4/2007              Instructor, HuBio 551 “Gut” course, University of Washington Medical School, 2nd Year Students

              5/2007              Instructor, Procedures course, University of Washington Medical School, 2nd Year Students

              1/2008              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

              4/2008              Instructor, HuBio 551 “Gut” course, University of Washington Medical School, 2nd Year Students

              4/2009              Contributor, HuBio 551 “Gut” course syllabus, University of Washington Medical School, 2nd Year Students

              1/2009              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

    1/2010              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

              4/2011              Contributor, HuBio 551 “Gut” course syllabus, University of Washington Medical School, 2nd Year Students

              4/2012              Contributor, HuBio 551 “Gut” course syllabus, University of Washington Medical School, 2nd Year Students

              5/2012              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

              4/2013              Contributor, HuBio 551, “Gut” course syllabus, and Lecturer, University of Washington Medical School, 2nd Year Students

              5/2013              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

              4/2014              Instructor, HuBio 511, “Gut” course Lecturer, University of Washington Medical School, 2nd Year Students

              3/2016              Instructor, LabM 685, University of Washington Medical School, Liver and Pancreas Section, 4th Year Students

             

             

Hospital and CME Teaching Presentations

              12/3/2005              CME, UW Medicine, “The Best of AASLD 2005—Genetic Liver Diseases and Portal Hypertension”

              11/15/2008              CME, UW Medicine, “The Best of AASLD 2008—Hepatitis B”

              9/12/2009               CME, Virginia Mason, “Hepatology Update 2009—Are Statins Safe?”

              9/14/2009              CME, UW Medicine, “37th Annual Advances in Family Practice—Diagnosis and Management of Liver Diseases:  A Case Based Approach”

    12/5/2009               CME, UW Medicine, “The Best of AASLD 2009—Hepatitis B”

    9/13/2010              CME, UW Medicine, “38th Annual Advances in Family Practice & Primary Care—Liver Diseases: A Case Based Approach”

    12/4/2010              CME, UW Medicine, “The Best of AASLD 2010—Other Highlights”

              12/3/2011              CME, UW Medicine, “The Best of AASLD 2011—Autoimmune and Metabolic Liver Disease & Portal Hypertension”

              9/13/2013              CME, UW Medicine, “41st Annual Advances in Family Practice & Primary Care—Primary Care Management of Hepatitis C”

              12/6/2014              CME, UW Medicine, “The Best of AASLD 2014—Alcoholic, Autoimmune, and Metabolic Liver Diseases”

              6/6/2016              CME, UW Medicine, Liver Care ECHO, “Updates in Hepatitis B: Highlights of 2016 AASLD Guidelines

              6/18/2016              CME, UW Medicine, “UW State-of-the-Art in Gastroenterology & Hepatology 2016—Hepatitis B”

             

             

              Housestaff Teaching Presentations/Courses

              6/2003              Group Leader, Intern ACLS Course, University of Washington

              4/2004              Group Leader, Intern ACLS Course, University of Washington

    4/14/2006              UWAMC Hepatology Grand Rounds, “Liver Diseases in Pregnancy”

    5/11/2007              UWAMC Hepatology Grand Rounds, “Autoimmune Hepatitis Overlap Syndromes”

    4/11/2008              UWAMC Hepatology Grand Rounds, “Halothane Hepatotoxicity”

              9/2/2008              UWAMC Internal Medicine Chairman’s Rounds, “Fulminant Hepatitis B”

              9/29/2008              UWAMC Internal Medicine Housestaff Teaching Conference, “Cirrhosis and Liver Transplantation”

              3/6/2009              UWAMC Transplant Resident Teaching Conference, “Prevention of HBV Recurrence after Liver Transplantation”

              3/10/2009              UWAMC Internal Medicine Chairman’s Rounds, “Fulminant Wilson’s Disease”

    4/10/2009              UWAMC Hepatology Grand Rounds, “Wilson Disease Cases”

    8/21/2009                  UWAMC GI Fellows’ Clinical Problem Solving Conference, “Cholestasis”

              9/18/2009              UWAMC Transplant Resident Teaching Conference, “Primary Non-Function after Liver Transplantation”

    10/16/2009              UWAMC Transplant Resident Teaching Conference, “Heart and Liver”

    1/13/2010              UWAMC Internal Medicine Housestaff Teaching Conference, “Cirrhosis and Liver Transplantation”

              1/15/2010                  UWAMC Hepatology Grand Rounds, “ANA Negative Autoimmune Hepatitis”

              4/23/2010              UWAMC Transplant Resident Teaching Conference, “Anti-HBc Positive Liver Donor”

    4/27/2010              UWAMC Internal Medicine Chairman’s Rounds, “Autoimmune Hepatitis in the Elderly”

              12/17/2010                UWAMC Transplant Resident Teaching Conference, “Leflunomide Hepatotoxicity”

    1/14/2011              UWAMC Hepatology Grand Rounds, “Infectious Hepatitis Case-Hepatitis E”

              4/20/2011              UWAMC Maternal Fetal Medicine Teaching Conference, “Pregnancy and Cirrhosis”

              6/11-6/12              UWAMC Monthly Internal Medicine ICU Teaching Conference, “Acute Liver Failure”

              8/25/2011              UWAMC Internal Medicine Housestaff Teaching Conference, “Liver Transplantation”

              8/29/2011              UWAMC Internal Medicine Resident Core Teaching Conference, “Abnormal Liver Tests”

              9/2/2011              UWAMC GI Fellow’ Clinical Problem Solving Conference, “Liver Disease in Pregnancy Cases”

              12/16/2011              UWAMC Transplant Resident Teaching Conference, “Diagnosis of Latent TB in Liver Transplant

                            Candidates”

              1/13/2012               UWAMC Hepatology Grand Rounds, “Liver Transplantation: Extensive Splanchnic Venous Thromboses”

              3/9/2012              UWAMC GI Fellows’ Clinical Problem Solving Conference, “Fulminant Hepatitis B”

              1/18/2013              UWAMC Transplant Grand Rounds, “Review of AASLD Guidelines on Long-Term Management of Adult

                            Liver Transplant”

              3/21/2014              UWAMC              Transplant Grand Rounds, “Acute Liver Failure Guidelines”

              12/12/2014              UWAMC              Transplant Grand Rounds, “Sarcopenia and Frailty in Liver Transplant Candidates”

              3/27/2015              UWAMC GI Journal Club, “Acute Liver Failure”

              12/11/15              UWAMC Transplant Grand Rounds, “Prevention of Hepatitis B Recurrence After Liver Transplantation”

              1/4/2016              UWAMC Medicine Resident Core Teaching Conference, “Hepatobiliary Diseases: Autoimmune Cases”

              2/12/2016              UWAMC Hepatology Grand Rounds, “Post Liver Transplant Ascites”

 

 

              Invited Teaching Presentations

              2/19/2015              UWAMC              Interventional Radiology Lecture Series, “Cirrhosis and Portal Hypertension”

 

1